Regulatory tracker: Biogen's ALS drug picks up approval in China
Welcome to Fierce Pharma's regulatory tracker for the second half of 2024. On this page, we're recording the regulatory progress of in-market products, including expansions into key geographies and new indications. UPDATED: Tuesday, October 8 at 9: …